Isoniazid-Induced Acne and Pellagra
- 1 March 1974
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 109 (3) , 377-381
- https://doi.org/10.1001/archderm.1974.01630030037008
Abstract
Seven patients with acneiform eruptions associated with isoniazid therapy, one of whom also had pellagra, were studied to determine whether they were slow or fast inactivators of isoniazid. Five patients, from 32 to 48 years of age, who had extensive eruptions were slow inactivators, as determined by the serum level of isoniazid six hours after administration and by serum half-life determination. Two patients, who were under 30 years of age and who had preexisting acne vulgaris and mild flares, were slow inactivators by serum half-life determination and were fast inactivators by six hour serum level determinations. Although not conclusive, the data are consistent with the hypothesis that slow inactivation of isoniazid is a significant determinant in those patients whose eruptions conform to the criteria discussed.Keywords
This publication has 10 references indexed in Scilit:
- Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritisThe American Journal of Medicine, 1973
- Isoniazid: A Review with Emphasis on Adverse EffectsChest, 1972
- DRUG REACTIONSBritish Journal of Anaesthesia, 1970
- Conjoint clinic on drugs and genesJournal of Chronic Diseases, 1965
- Reactions to IsoniazidArchives of Dermatology, 1963
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960
- Reactions to Antituberculous Drugs11From the Veterans Administration Hospital, Baltimore, Maryland.Journal of Investigative Dermatology, 1959
- ACUTE PELLAGRA DURING ISONIAZID THERAPYThe Lancet, 1952
- NICOTINIC ACID AND BURNING FEETThe Lancet, 1952
- Dysfunction of the Sebaceous Glands Associated with Pellagra121Read before the 3rd Annual Meeting of the Society for Investigative Dermatology, New York, June 11, 1940.2A part of the cost of hospitalizating these patients was borne by a grant from the Lederle Laboratories, Pearl River, New York.Journal of Investigative Dermatology, 1941